ArticleEpidemiology and infection2021
Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands.
Article in Epidemiology and infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Transmission pathways and risk factors for sporadic salmonellosis and campylobacteriosis: a source attribution meta-analysis of European case-control studies.Epidemiology and infection · 2025Pooled it
- A statistical modelling approach for source attribution meta-analysis of sporadic infection with foodborne pathogens.Zoonoses and public health · 2022Pooled it
- Salmonellosis Among Children Aged 0-14 Years in Greece over the Period 2005-2024: Descriptive Analysis of Surveillance Data from the Mandatory Notification System.Microorganisms · 2026Article
- Article
- Persistence of non-typhoidalFrontiers in microbiology · 2026Review
- COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study.BMJ global health · 2025Article
- Impact of the COVID-19 pandemic on five food- and waterborne diseases in six European countries, 2016-21.European journal of public health · 2025Article
- Global Impact of COVID-19 Pandemic on Gastrointestinal Infections: A Scoping Review.Foodborne pathogens and disease · 2025Article
- Epidemiological features of nontyphoidal Salmonella infections reported to foodborne disease surveillance system in china, 2013-2022.BMC public health · 2025Article
- Assessing the impact of the COVID-19 pandemic on trends of select travel-acquired enteric illnesses in Canada.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025Article
- The changing landscape of nontyphoidal salmonellosis: epidemiological patterns, imported cases and serovar distribution in Germany from 2012 to 2023.BMC infectious diseases · 2025Article
- Genomic epidemiology ofMicrobial genomics · 2025Article
- Reporting of Salmonellosis Markedly Declined in Finland During 28 Years of Surveillance, 1995-2022.Microorganisms · 2025Article
- Epidemiological Changes in Acute Febrile Diseases after the COVID-19 Pandemic in Thailand.The American journal of tropical medicine and hygiene · 2025Article
- Impact of non-pharmaceutical interventions during the COVID-19 pandemic on pathogens transmitted via food in the Netherlands.Epidemiology and infection · 2024Article
- Risk Factors forPathogens (Basel, Switzerland) · 2024Article
- Impact of COVID-19-related nonpharmaceutical interventions on diarrheal diseases and zoonotichLife · 2024Article
- Antimicrobial Resistance in Qatar: Prevalence and Trends before and Amidst the COVID-19 Pandemic.Antibiotics (Basel, Switzerland) · 2024Article
- Genetic Diversity ofPathogens (Basel, Switzerland) · 2024Article
- Characteristics of Gastroenteritis Outbreaks Investigated in Singapore: 2018-2021.International journal of environmental research and public health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The public health measures implemented to control coronavirus disease 2019 (COVID-19) may influence also other infectious diseases. Using national laboratory surveillance data, we assessed the impact of the COVID-19 pandemic on human salmonellosis in the Netherlands until March 2021. Salmonellosis incidence decreased significantly after March 2020: in the second, third and fourth quarters of 2020, and in the first quarter of 2021, the incidence decreased by 55%, 57%, 47% and 37%, respectively, compared to the same quarters of 2016-2019. The decrease was strongest among travel-related cases (94%, 84%, 79% and 93% in the aforementioned quarters, respectively). Other significant changes were: increased proportion of cases among older adults and increased proportion of invasive infections, decreased proportion of trimethoprim resistance and increased proportion of serovar Typhimurium monophasic variant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.